» Articles » PMID: 30192869

Rotavirus VP6 Protein Mucosally Delivered by Cell Wall-derived Particles from Lactococcus Lactis Induces Protection Against Infection in a Murine Model

Overview
Journal PLoS One
Date 2018 Sep 8
PMID 30192869
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Rotaviruses are the primary cause of acute gastroenteritis in children worldwide. Although the implementation of live attenuated vaccines has reduced the number of rotavirus-associated deaths, variance in their effectiveness has been reported in different countries. This fact, among other concerns, leads to continuous efforts for the development of new generation of vaccines against rotavirus.In this work, we describe the obtention of cell wall-derived particles from a recombinant Lactococcus lactis expressing a cell wall-anchored version of the rotavirus VP6 protein. After confirming by SDS-PAGE, Western blot, flow cytometry and electronic immunomicroscopy that these particles were carrying the VP6 protein, their immunogenic potential was evaluated in adult BALB/c mice. For that, mucosal immunizations (oral or intranasal), with or without the dmLT [(double mutant Escherichia coli heat labile toxin LT(R192G/L211A)] adjuvant were performed. The results showed that these cell wall-derived particles were able to generate anti-rotavirus IgG and IgA antibodies only when administered intranasally, whether the adjuvant was present or not. However, the presence of dmLT was necessary to confer protection against rotavirus infection, which was evidenced by a 79.5 percent viral shedding reduction.In summary, this work describes the production of cell wall-derived particles which were able to induce a protective immune response after intranasal immunization. Further studies are needed to characterize the immune response elicited by these particles as well as to determine their potential as an alternative to the use of live L. lactis for mucosal antigen delivery.

Citing Articles

Biotechnological Interventions for the Production of Subunit Vaccines Against Group A Rotavirus.

Prajapati M, Malik P, Sinha A, Yadav H, Jaiwal Y, Ahlawat Y Cell Biochem Funct. 2024; 42(8):e70031.

PMID: 39707603 PMC: 11662099. DOI: 10.1002/cbf.70031.


Production of Bovine Rotavirus VP6 Subunit Vaccine in a Transgenic Fodder Crop, Egyptian Clover (Berseem, Trifolium alexandrinum) that Elicits Immune Responses in Rabbit.

Malik P, Prajapati M, Chaudhary D, Prasad M, Jaiwal R, Jaiwal P Mol Biotechnol. 2023; 65(9):1432-1443.

PMID: 36637627 DOI: 10.1007/s12033-022-00648-0.


Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health.

Levit R, Cortes-Perez N, de Moreno de LeBlanc A, Loiseau J, Aucouturier A, Langella P Gut Microbes. 2022; 14(1):2110821.

PMID: 35960855 PMC: 9377234. DOI: 10.1080/19490976.2022.2110821.


Rotavirus vaccines: progress and new developments.

Cates J, Tate J, Parashar U Expert Opin Biol Ther. 2021; 22(3):423-432.

PMID: 34482790 PMC: 10839819. DOI: 10.1080/14712598.2021.1977279.


Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease.

Taghinezhad-S S, Mohseni A, Bermudez-Humaran L, Casolaro V, Cortes-Perez N, Keyvani H Vaccines (Basel). 2021; 9(5).

PMID: 34066443 PMC: 8148110. DOI: 10.3390/vaccines9050466.


References
1.
Burns J, Krishnaney A, Greenberg H . Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science. 1996; 272(5258):104-7. DOI: 10.1126/science.272.5258.104. View

2.
Enouf V, Langella P, Commissaire J, Cohen J, Corthier G . Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic. Appl Environ Microbiol. 2001; 67(4):1423-8. PMC: 92750. DOI: 10.1128/AEM.67.4.1423-1428.2001. View

3.
Franco M, Greenberg H . Immunity to rotavirus infection in mice. J Infect Dis. 1999; 179 Suppl 3:S466-9. DOI: 10.1086/314805. View

4.
Bermudez-Humaran L . Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins. Hum Vaccin. 2009; 5(4):264-7. DOI: 10.4161/hv.5.4.7553. View

5.
Li Y, Ma G, Li G, Qiao X, Ge J, Tang L . Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production. J Biomed Biotechnol. 2010; 2010:708460. PMC: 2896853. DOI: 10.1155/2010/708460. View